6505--Notice of Intent to Award a Sole Source Procurement - Xofigo (Ra223)

The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Cardinal Health for the procurement of 1,000 units of XOFIGO® (Radium-223 dichloride), with each unit measured in electron volts per curie (uCi). This procurement is designated as a sole source under 41 U.S.C. 3304(a)(1) and FAR 6.302-1, as Bayer Healthcare, the manufacturer of XOFIGO®, has exclusively designated Cardinal Health as its sole distributor for this radiopharmaceutical in the United States, leaving no other responsible source capable of fulfilling the requirement. The price for the product is established by Bayer Healthcare and will be applied without competitive bidding. Although this notice is not a formal request for proposals or quotations, any responsible source may submit a capability statement, proposal, or quotation by the deadline of June 8, 2026, at 3:00 PM Central Time to demonstrate the availability of a comparable source that may be more advantageous to the government. If no such submissions are received within seven days of the notice’s publication, the contract will be awarded to Cardinal Health without further solicitation or public notice. The NAICS code for this action is 325412, reflecting pharmaceutical preparation manufacturing, and the Product Service Code is 6505. The procuring office is located in San Antonio, Texas, and inquiries should be directed to Contract Specialist Vance Farrell. No contract clauses, delivery schedules, inspection criteria, packaging requirements, or award evaluation factors are included in this presolicitation notice, as it serves solely to alert the public of the intent to proceed with a non-competitive award based on statutory exclusivity.